53179-09-2

• 常用中文名：硫酸西索米星
• 常用英文名：Sisomycin Sulfate
• CAS号：53179-09-2
• 分子式：C₃₈H₈₄N₁₀O₃₄S₅
• 分子量：1385.5
• 相关类别： 原料药 抗生素类药物 氨基糖苷类药
• 发布时间：2018-03-24 08:00:00
• 更新时间：2026-07-01 14:31:49
• Sisomicin硫酸盐是一种氨基糖苷类抗生素。

名称

• 中文名: 硫酸西梭霉素
• 英文名: Sisomicin sulfate
• 中文别名: O-3-脱氧-4-C-甲基-3-甲氨基-Β-L-阿拉伯糖吡喃糖基(1→4)-O-[2,6-二氨基-2,3,4,6-四脱氧-Α-D-甘油型-4-己烯吡喃糖基-(1→6)]-2-脱氧-L-链霉胺硫酸盐(2:5); 西索紫苏; 硫酸西梭米星; 硫酸西索米星, 580 IU/MG; 西索米星(硫酸西索米星); 硫酸西索紫苏; 硫酸西索米星/硫酸西索霉素; 硫酸西索米星/紫苏霉素; 硫酸西索紫苏 标准品; 双((2R,3R,4R,5R)-2-(((1S,2S,3R,4S,6R)-4,6-二氨基-3-(((2S,3R)-3-氨基-6-(氨基甲基)-3,4-二氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-5-甲基-4-(甲基氨基)四氢-2H-吡喃-3,5-二醇) 五(硫酸盐); 硫酸西梭米星/硫酸西索霉素; 硫酸西索米星/C1A; 硫酸西索米星 53-2; 西索米星(标准品); 硫酸西索米星 标准品; 硫酸西梭米星/硫酸西索霉素/西索米星; 硫酸西索米星,硫酸西梭霉素
• 英文别名: Sisomicin sulfate, >=580 μg/mg; Extramycin; Siseptin; sisomin; D-StrtaMine, O-3-deoxy-4-C-Methyl-3-(MethylaMino)-β-L-abinopyranosyl-(1→6)-O-[2,6-diaMino-2,3,4,6-tetradeoxy-α-D-glycero-hex-4-enopyranosyl-(1→4)]-2-deoxy-, sulfate (2:5) (salt); Sisomicin Sulfate; Pathomycin; Baymicin; sisomicin sulfate; Sisolline; Sisobiotic; Sisomicin SulphateQ: What is Sisomicin Sulphate Q: What is the CAS Number of Sisomicin Sulphate Q: What is the storage condition of Sisomicin Sulphate Q: What e the applications of Sisomicin Sulphate; Netilmicin Sulfate Impurity A as Sulfate; D-Strtamine, O-3-deoxy-4-C-methyl-3-(methylamino)-b-L-abinopyranosyl-(16)-O-[2,6-diamino-2,3,4,6-tetradeoxy-a-D-glycero-hex-4-enopyranosyl-]-2-deoxy-, sulfate (2:5) (salt) (9CI); Antibiotic 66-40 sulfate; O-3-Deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl(1®6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-a-D-glycero-hex-4-enopyranosyl-(1®4)]-2-deoxy-D-streptamine Sulfate (2:5) (Salt); Sch 13475 sulfate; Sisomycin Sulfate //BP; SISOMICIN SULFATE SALT; (1S,2S,3R,4S,6R)-4,6-Diamino-3-{[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy}-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranoside sulfate (2:5); Bis((2R,3R,4R,5R)-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-5-methyl-4-(methylamino)tetrahydro-2H-pyran-3,5-diol) pentakis(sulfate); extramycin; Sisomycin sulfate; Sisomicin sulfate, 580 IU/mg; Sisomin; O-3-DEOXY-4-C-METHYL-3-METHYLAMINO-BETA-L-ABINOPYRANOSYL-(1-)-O-[2, 6-DIAMINO-4,5-DEHYDRO-2,3,4,6-TETRADEOXY-A-D-GLYCERO-HEXOPYRANOSYL-(1-)]-2-DEOXY-D-STRTAMINE HEMIHTASULFATE; β-L-Arabinopyranoside, (1S,2S,3R,4S,6R)-4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)-, sulfate (2:5) (salt); O-3-Deoxy-4-C-methyl-3-methylamino-ss-L-abinopyranosyl-(1-)-O-[2, 6-diamino-4, 5-dehydro-2,3,4,6-tetradeoxy-a-D-glycero-hexopyranosyl-(1-)]-2-deoxy-D-strtamine hemihtasulfate; Gentamicin Sulfate Impurity A as Sulfate; Disisomicinpentakis(sulfat); O-3-Deoxy-4-C-methyl-3-(methylamino)-β-L-abinopyranosyl-(1→4)-O-[2，6-diamino-2，3，4，6-tetradeoxy-α-D-glycero-hex-4-enopyranosyl-(1 → 6)]-2-deoxy-L -strtamine sulfate (2:5)(salt); O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L-abinopyranosyl-O-[2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-]-2-deoxy-D-strtamine sulfate; mensiso; sisomycinsulfate; TIANFU CHEM-SISOMICIN SULFATE; pathomycin; disisomicin pentakis(sulphate); First International Standd for Sisomicin; Sulfuric acid west shuttle m st; (2S-cis)-4-O-[3-Amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]-2-deoxy-6-O-[3-deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl]-D-streptamine Sulfate (2:5) (Salt); Mensiso; 6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-glycero-hex-4-enopyranosyl-); antibiotic66-40sulfate; SISOMYCIN SULPHATE; Sisomicin sulfate CRS; Sissomicin sulfate

物化性质

• 沸点: 676.6ºC at 760mmHg
• 熔点: 70-73ºC
• 分子式: C₃₈H₈₄N₁₀O₃₄S₅
• 分子量: 1385.5
• 闪点: 363ºC
• 精确质量: 1384.3754956
• PSA: 842.34000
• LogP: 0.82120
• 外观性状: white to off-white
• 储存条件: 库房通风低温干燥,与食品原料分开存放
• 水溶解性: H2O: soluble50mg/mL | Soluble in water

生物活性

• 描述: Sisomicin硫酸盐是一种氨基糖苷类抗生素。
• 相关类别:
  信号通路 >> 抗感染 >> 细菌
  研究领域 >> 感染
  天然产物 >> 其他

毒性和生态

CHEMICAL IDENTIFICATION RTECS NUMBER : WK2288000 CAS REGISTRY NUMBER : 53179-09-2 LAST UPDATED : 199510 DATA ITEMS CITED : 14 MOLECULAR FORMULA : C19-H37-N5-O7.5/2H2-O4-S MOLECULAR WEIGHT : 692.81 HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : >5 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,320,1982 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 500 mg/kg TOXIC EFFECTS : Behavioral - tremor Behavioral - muscle weakness Lungs, Thorax, or Respiration - other changes REFERENCE : JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 4,107,1978 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 49 mg/kg TOXIC EFFECTS : Behavioral - tremor Behavioral - muscle weakness Lungs, Thorax, or Respiration - other changes REFERENCE : JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 4,107,1978 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 404 mg/kg TOXIC EFFECTS : Behavioral - tremor Behavioral - muscle weakness Lungs, Thorax, or Respiration - other changes REFERENCE : JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 4,107,1978 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : >5 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,320,1982 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 221 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968- Volume(issue)/page/year: 23,551,1970 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 272 mg/kg TOXIC EFFECTS : Behavioral - tremor Behavioral - muscle weakness Lungs, Thorax, or Respiration - other changes REFERENCE : JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 4,107,1978 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 34 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968- Volume(issue)/page/year: 23,551,1970 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 280 mg/kg TOXIC EFFECTS : Behavioral - tremor Behavioral - muscle weakness Lungs, Thorax, or Respiration - other changes REFERENCE : JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 4,107,1978 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Mammal - dog DOSE/DURATION : 267 mg/kg TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - ataxia Lungs, Thorax, or Respiration - dyspnea REFERENCE : JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 10,43,1984 ** OTHER MULTIPLE DOSE TOXICITY DATA ** TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 840 mg/kg/28D-I TOXIC EFFECTS : Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis) Kidney, Ureter, Bladder - urine volume increased Kidney, Ureter, Bladder - changes in bladder weight REFERENCE : JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 4,107,1978 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 2912 mg/kg/26W-I TOXIC EFFECTS : Kidney, Ureter, Bladder - urine volume increased Kidney, Ureter, Bladder - changes in bladder weight Nutritional and Gross Metabolic - weight loss or decreased weight gain REFERENCE : JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 4,107,1978 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 700 mg/kg/4W-I TOXIC EFFECTS : Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical - Metabolism (Intermediary) - other proteins REFERENCE : ANTBAL Antibiotiki. (Moscow, USSR) V.1-29, 1956-84. For publisher information, see AMBIEH. Volume(issue)/page/year: 28,678,1983 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Mammal - cat DOSE/DURATION : 2170 mg/kg/70D-I TOXIC EFFECTS : Behavioral - altered sleep time (including change in righting reflex) Behavioral - ataxia Related to Chronic Data - death REFERENCE : JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968- Volume(issue)/page/year: 23,559,1970

安全

• 符号: GHS07, GHS08
• 信号词: Danger
• 危害声明: H312 + H332-H360
• 警示性声明: P201-P261-P280-P308 + P313
• 个人防护装备: Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
• 危害码 (欧洲): T,Xi
• 风险声明 (欧洲): 61-20/21/22-36/37/38
• 安全声明 (欧洲): 53-22-36/37/39-45-36-26
• 危险品运输编码: NONH for all modes of transport
• WGK德国: 3
• RTECS号: WK2288000

上下游产品

上游产品  0
下游产品  1
32385-11-8